WEDNESDAY, Sept. 6, 2023 (HealthDay News) — Cancer is surging among people under 50, a new global study reveals. Over the past 30 years, new cases have increased 79% worldwide in that age bracket, according to a report published Sept. 5 in BMJ Oncology. The fastest rising cancers are inContinue Reading
TUESDAY, Sept. 5, 2023 (HealthDay News) — Smoking may not only harm the smoker and those who breathe in the secondhand fumes, but also their future children. New research suggests that boys who smoke in their early teens risk passing on harmful genetic traits to future children. The study probedContinue Reading
WEDNESDAY, Aug. 30, 2023 (HealthDay News) — Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone. Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine. Treating childhood obesity and type 2 diabetes withContinue Reading
TUESDAY, Aug. 29, 2023 (HealthDay News) — An apple a day may be just what the doctor ordered. New research on “produce prescription” programs finds that when access to free fruits and vegetables is offered, recipients see measurable benefits in health and hunger. “To me, this shows that there’s aContinue Reading
TUESDAY, Aug. 29, 2023 (HealthDay News) — For women, keeping a stable weight after the age of 60 may boost their odds of reaching the advanced ages of 90, 95 or even 100. Older women with a more stable weight were 1.2 to 2 times more likely to live thatContinue Reading
TUESDAY, Aug. 29, 2023 (HealthDay News) — Using ECMO, a highly advanced form of breathing support, does not appear to complicate treatment for obese adults in intensive care. ECMO, which is short for extracorporeal membrane oxygenation, may even help these patients when they experience respiratory failure, despite the fact thatContinue Reading
FRIDAY, Aug. 25, 2023 (HealthDay News) — Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing. Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. TheContinue Reading
MONDAY, Aug. 14, 2023 (HealthDay News) — A more personalized approach to exercise may be necessary, claims a new study that found fat burning varied widely between individuals. Even worse, this rate often does not align with the “fat-burning zone” on commercial exercise machines, the researchers added. Clinical exercise testing,Continue Reading
FRIDAY, Aug. 11, 2023 (HealthDay News) – As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024. The new plan extends by months existing restrictions and means patients whoContinue Reading
TUESDAY, Aug. 8, 2023 (HealthDay News) — A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect. Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday. “People living with obesity haveContinue Reading